Transcription Factor Sp1 Is Involved in Expressional Regulation of Coxsackie and Adenovirus Receptor in Cancer Cells

被引:5
|
作者
Chung, Sun-Ku [1 ,2 ]
Kim, Joo-Young [1 ,3 ]
Lim, Joong-Yeon [1 ]
Park, Young Mi [1 ]
Hwang, Ha-Young [1 ]
Nam, Jae-Hwan [4 ]
Park, Sang Ick [1 ]
机构
[1] Natl Inst Hlth, Ctr Biomed Sci, Div Intractable Dis, Cheongwon Gun 363951, Chungcheongbuk, South Korea
[2] Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, La Jolla, CA 92093 USA
[3] Korea Univ, Sch Life Sci & Biotechnol, Seoul 136701, South Korea
[4] Catholic Univ Korea, Dept Biotechnol, Gyeonggi Do 420743, Bucheon, South Korea
来源
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY | 2011年
关键词
DEACETYLASE INHIBITOR FR901228; HUMAN BLADDER-CANCER; TRANSGENE EXPRESSION; MALIGNANT-CELLS; GROWTH; CAR; PROMOTER; BINDING;
D O I
10.1155/2011/636497
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Coxsackie and adenovirus receptor (CAR) was first known as a virus receptor. Recently, it is also known to have tumor suppressive activity such as inhibition of cell proliferation, migration, and invasion. It is important to understand how CAR expression can be regulated in cancers. Based on an existence of putative Sp1 binding site within CAR promoter, we investigated whether indeed Sp1 is involved in the regulation of CAR expression. We observed that deletion or mutation of Sp1 binding motif (-503/-498) prominently impaired the Sp1 binding affinity and activity of CAR promoter. Histone deacetylase inhibitor (TSA) treatment enhanced recruitment of Sp1 to the CAR promoter in ChIP assay. Meanwhile, Sp1 binding inhibitor suppressed the recruitment. Exogenous expression of wild-type Sp1 increased CAR expression in CAR-negative cells; meanwhile, dominant negative Sp1 decreased the CAR expression in CAR-positive cells. These results indicate that Sp1 is involved in regulation of CAR expression.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Downregulation of the coxsackie and adenovirus receptor in cancer cells by hypoxia depends on HIF-1α
    Kuester, K.
    Koschel, A.
    Rohwer, N.
    Fischer, A.
    Wiedenmann, B.
    Anders, M.
    CANCER GENE THERAPY, 2010, 17 (02) : 141 - 146
  • [42] Sp1 is a key regulator of the PDGF β-receptor transcription
    Molander, C
    Hackzell, A
    Ohta, M
    Izumi, H
    Funa, K
    MOLECULAR BIOLOGY REPORTS, 2001, 28 (04) : 223 - 233
  • [43] Glucagon paradoxically both stimulates and inhibits Sp1 transcription factor: Studies of mechanisms involved
    Keembiyehetty, C
    Candelaria, R
    Raghow, R
    Solomon, S
    DIABETES, 2001, 50 : A312 - A312
  • [44] Overexpression of Sp1 transcription factor induces apoptosis
    Deniaud, E.
    Baguet, J.
    Mathieu, A-L
    Pages, G.
    Marvel, J.
    Leverrier, Y.
    ONCOGENE, 2006, 25 (53) : 7096 - 7105
  • [45] Cell density and expression of transcription factor Sp1
    Cheng, EL
    Li, Y
    Sugar, J
    Yue, BYJT
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1999, 40 (04) : S330 - S330
  • [46] NUCLEOSOME BINDING BY THE CONSTITUTIVE TRANSCRIPTION FACTOR SP1
    LI, BY
    ADAMS, CC
    WORKMAN, JL
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1994, 269 (10) : 7756 - 7763
  • [47] Expression of PACT is regulated by Sp1 transcription factor
    Fasciano, Stephen
    Kaufman, Amanda
    Patel, Rekha C.
    GENE, 2007, 388 (1-2) : 74 - 82
  • [48] Overexpression of Sp1 transcription factor induces apoptosis
    E Deniaud
    J Baguet
    A-L Mathieu
    G Pagès
    J Marvel
    Y Leverrier
    Oncogene, 2006, 25 : 7096 - 7105
  • [49] δ-Opioid receptor gene:: Effect of Sp1 factor on transcriptional regulation in vivo
    Smirnov, D
    Im, HJ
    Loh, HH
    MOLECULAR PHARMACOLOGY, 2001, 60 (02) : 331 - 340
  • [50] Targeting the Sp1 Transcription Factor in Multiple Myeloma
    Fulciniti, M.
    Tassone, P.
    Hideshima, T.
    Nanjappa, P.
    Prabhala, R.
    Podar, K.
    Amin, S.
    Adamia, S.
    Anderson, K. C.
    Munshi, N. C.
    Lopez, R.
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S152 - S152